Survivorship Sequelae of Precision Breast Cancer Treatments: Defining the impacts of immunotherapy and PARP inhibitors on ovarian function and fertility

  • Hutt, Karla (Primary Chief Investigator (PCI))
  • Phillips, Kelly Anne (Chief Investigator (CI))
  • Loi, Sherene (Chief Investigator (CI))
  • Winship, Amy (Chief Investigator (CI))
  • Cui, Wanyuan (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date23/03/22 → 31/12/24

Funding

  • National Breast Cancer Foundation: A$370,132.05